Divergent effect of endogenous and exogenous sex steroids on the insulin-like growth factor I response to growth hormone in short normal adolescents

被引:28
作者
Coutant, R
De Casson, FB
Rouleau, S
Douay, O
Mathieu, E
Gatelais, F
Bouhours-Nouet, N
Voinot, C
Audran, M
Limal, JM
机构
[1] Univ Hosp, Dept Pediat, F-49000 Angers, France
[2] Univ Hosp, Dept Nucl Med, F-49000 Angers, France
[3] Univ Hosp, Dept Biochem, F-49000 Angers, France
[4] Univ Hosp, Dept Rheumatol, F-49000 Angers, France
[5] INSERM, U0335, F-49000 Angers, France
关键词
D O I
10.1210/jc.2004-0814
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The lower responsiveness to GH in women than in men is probably due to a divergent effect of gonadal steroids. It is unknown, however, how the progressive increase in sex steroid production that occurs during puberty affects this responsiveness. To compare the effects of puberty and sex steroid administration on responsiveness to GH, we used the IGF-I generation test, in which the peak IGF-I level 24 h after a single injection of GH (2 mg/m(2)) was studied in 117 healthy short subjects (56 females and 61 males). The subjects, aged 8-16 yr, were divided into four groups: prepuberty, early puberty, midpuberty, or pubertal delay. In the latter group, the IGF-I response was determined before and after priming with oral 17beta-estradiol in girls and im testosterone in boys. We also tested for an association between body composition (by dual energy x-ray absorptiometry) and the IGF-I response to GH. The IGF-I increment in response to GH (change in IGF-I from baseline) was correlated with the growth velocity SD score (P < 0.05). Progression throughout puberty was associated with an increase in both baseline IGF-I (P < 0.05) and the IGF-I-increment in response to GH (P < 0.05), with no gender difference. Pubertal category (pre-, early, and midpuberty; P < 0.05) and fat percentage (P < 0.05) were the main positive predictors of the IGF-I increment in response to GH, expressed as micrograms per liter as well as SD score, independently of baseline IGF-I. After sex steroid priming, both the GH peak in response to insulin-induced hypoglycemia and baseline IGF-I were increased (P < 0.05, after vs. before sex steroid). However, the IGF-I increment in response to GH decreased after oral 17beta-estradiol (P < 0.05), whereas it was unchanged after testosterone administration. Endogenous gonadal steroid secretion appears to result in increased responsiveness to GH in peripubertal girls and boys. By contrast, exogenous estrogen and testosterone, respectively, produce a relative decrease and no change in responsiveness to GH in similar populations, possibly through the achievement of sex steroid concentrations exceeding physiological ranges for age. Fat percentage was a positive determinant of the responsiveness to GH, suggesting a link between the energy stores and the anabolic action of GH.
引用
收藏
页码:6185 / 6192
页数:8
相关论文
共 53 条
[11]   Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults [J].
Cook, DM ;
Ludlam, WH ;
Cook, MB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (11) :3956-3960
[12]   The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men [J].
Dall, R ;
Longobardi, S ;
Ehrnborg, C ;
Keay, N ;
Rosén, T ;
Jorgensen, JOL ;
Cuneo, RC ;
Boroujerdi, MA ;
Cittadini, A ;
Napoli, R ;
Christiansen, JS ;
Bengtsson, BA ;
Sacca, L ;
Baxter, RC ;
Basset, EE ;
Sönksen, PH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (11) :4193-4200
[13]   INSULIN-LIKE GROWTH FACTOR-I AND FACTOR-II - PEPTIDE, MESSENGER RIBONUCLEIC-ACID AND GENE STRUCTURES, SERUM, AND TISSUE CONCENTRATIONS [J].
DAUGHADAY, WH ;
ROTWEIN, P .
ENDOCRINE REVIEWS, 1989, 10 (01) :68-91
[14]   Optimizing GH therapy in adults and children [J].
Drake, WM ;
Howell, SJ ;
Monson, JP ;
Shalet, SM .
ENDOCRINE REVIEWS, 2001, 22 (04) :425-450
[15]   The effects of testosterone and dihydrotestosterone on hypothalamic regulation of growth hormone secretion [J].
Eakman, GD ;
Dallas, JS ;
Ponder, SW ;
Keenan, BS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (03) :1217-1223
[16]   Both oral and transdermal estrogen increase growth hormone release in postmenopausal women - A clinical research center study [J].
Friend, KE ;
Hartman, ML ;
Pezzoli, SS ;
Clasey, JL ;
Thorner, MO .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (06) :2250-2256
[17]   Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and women [J].
Ghigo, E ;
Aimaretti, G ;
Maccario, M ;
Fanciulli, G ;
Arvat, E ;
Minuto, F ;
Giordano, G ;
Delitala, G ;
Camanni, F .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1999, 276 (06) :E1009-E1013
[18]   MUTATIONS OF THE GROWTH-HORMONE RECEPTOR IN CHILDREN WITH IDIOPATHIC SHORT STATURE [J].
GODDARD, AD ;
COVELLO, R ;
LUOH, SM ;
CLACKSON, T ;
ATTIE, KM ;
GESUNDHEIT, N ;
RUNDLE, AC ;
WELLS, JA ;
CARLSSON, LMS .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (17) :1093-1098
[19]  
Grumbach M.M., 2003, WILLIAMS TXB ENDOCRI, V10th, P1115
[20]   Effect of intraperitoneal insulin delivery on growth hormone binding protein, insulin-like growth factor (IGF)-I, and IGF-binding protein-3 in IDDM [J].
HanaireBroutin, H ;
SallerinCaute, B ;
Poncet, MF ;
Tauber, M ;
Bastide, R ;
Chale, JJ ;
Rosenfeld, R ;
Tauber, JP .
DIABETOLOGIA, 1996, 39 (12) :1498-1504